19 Mar 2021
Posted in Medical Devices
Deep-Vein Thrombosis Awareness Month will increase market value for clot management devices, says GlobalData
Deep vein thrombosis (DVT) occurs in just over 300,000 people per year in the US alone, according to GlobalData, and this number is growing every year. The leading data and analytics company notes that campaigns such as Deep-Vein Thrombosis Awareness Month will greatly contribute towards raising public awareness about the condition and, in turn, help drive market value for clot management devices.
Ashley Young, Medical Devices Analyst at GlobalData, comments: “DVT symptoms can often be mild or confused with other disorders. Ignoring or misinterpreting these can increase the possibility of developing more severe symptoms such as pulmonary embolism, which, according to GlobalData estimates, has a mortality rate of approximately 25% in the US.
“Public campaigns such as Deep-Vein Thrombosis Awareness Month will help educate the population on how to recognize these signs, which will lead to a greater diagnosis rate.”
Currently, there are several treatment options available for DVT, including medication, compression and surgery. Surgical options include treatment with a variety of clot management devices, including thrombectomy systems, catheter-directed thrombolysis and embolectomy balloon catheters.
Young continues: “GlobalData estimates that the total market value for clot management devices in the US was just under $350m in 2019. Although the usage of these devices was impacted by the COVID-19 pandemic, GlobalData predicts that their market value will return to pre-pandemic levels in 2021.”